Bionexus Gene Lab vs Quantum-si
Bionexus Gene Lab is the larger business, with $7.4m of revenue in fiscal 2025 against $2.4m for Quantum-si (3.0 times as much). Quantum-si grew faster (-20.3% against -21.9%). Bionexus Gene Lab kept more of each dollar of sales as profit: a net margin of -40.2% against -4160.1%.
| Latest fiscal year | Bionexus Gene LabBGLC, 2025 | Quantum-siQSI, 2025 |
|---|---|---|
| Revenue | $7.4m | $2.4m |
| Revenue growth | -21.9% | -20.3% |
| Net income | −$3.0m | −$101m |
| Operating margin | — | — |
| Net margin | -40.2% | -4160.1% |
| Return on equity | -35.2% | -46.5% |
| Free cash flow | −$1.9m | −$97.2m |
| Cash | $2.4m | $21.6m |
| Total debt | $0 | $0 |
| Debt to equity | — | — |
| Dividend per share | — | — |
| Dividend yield | — | — |
| Share buybacks | — | — |
| Employees | — | 138 |
| Market value | $2.3m | $281m |
| Price vs our value range | — | — |
| Moat score | 23 (Weak) | — |
| Insider trades, 12 months | 0 buys, 0 sales | 2 buys, 30 sales |